![]() Rein Therapeutics Rein Therapeutics (formerly known as Aileron Therapeutics) is a clinical-stage biopharmaceutical company that develops medicines targeting undruggable cancer sites using its proprietary platform of stabilized cell-permeating peptides. | Barinthus Biotherapeutics Barinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. | ![]() Salarius Pharmaceuticals Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments. | ![]() Gliknik Gliknik is a biopharmaceutical company creating therapies for people living with cancer and immune disorders. | ||
Founding Date | Founding Date N/A | Founding Date 2005 | Founding Date 2016 | Founding Date 2011 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations New York, US HQ | Locations Watertown, US HQ Boston, US | Locations Oxford, GB HQ | Locations Houston, US HQ | Locations Baltimore, US HQ |
Employees | Employees 2 | Employees 838% decrease | Employees 33 | Employees 2 | Employees 9 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 90.2 m | Valuation ($) 57.2 m | Valuation ($) 2.4 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($49.9m) (FY, 2025) | Net income ($66.5m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 112m | Total funding raised $ 195.1m | Total funding raised N/A | Total funding raised $ 65.1m |

Rein Therapeutics (formerly known as Aileron Therapeutics) is a clinical-stage biopharmaceutical company that develops medicines targeting undruggable cancer sites using its proprietary platform of stabilized cell-permeating peptides.
View companyBarinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases.
View company
Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.
View company
Gliknik is a biopharmaceutical company creating therapies for people living with cancer and immune disorders.
View company